MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE
    31.
    发明申请
    MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE 有权
    MACROCYCLIC LACTONE化合物及其使用方法

    公开(公告)号:US20120093891A1

    公开(公告)日:2012-04-19

    申请号:US13333526

    申请日:2011-12-21

    摘要: The present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of the formula: wherein R1, R2, R3, R5, R6 and R8 are each independently a member selected from the group consisting of H, C1-6 alkyl and OH; R4, R7 and R9 are each independently selected from the group consisting of C1-6 alkoxy and OH; R10 is a member selected from the group consisting of H, —OH, —OP(O)Me2, —O—(CH2)n—OH and —O—(CH2)m—O—(CH2)o—CH3, wherein subscripts n and m are each independently from 2 to 8 and subscript o is from 1 to 6; each of L1 and L4 are independently selected from the group consisting of: each of L2 and L3 are independently selected from the group consisting of: and salts, hydrates, isomers, metabolites and prodrugs thereof.

    摘要翻译: 本发明提供包含药学上可接受的赋形剂和下式化合物的药物组合物:其中R 1,R 2,R 3,R 5,R 6和R 8各自独立地选自H,C 1-6烷基和OH ; R 4,R 7和R 9各自独立地选自C 1-6烷氧基和OH; R 10是选自H,-OH,-OP(O)Me 2,-O-(CH 2)n -OH和-O-(CH 2)m -O-(CH 2)o -CH 3的成员,其中 下标n和m各自独立地为2至8,下标o为1至6; L1和L4中的每一个独立地选自以下各项:L2和L3各自独立地选自:和其盐,水合物,异构体,代谢物和前药。

    DYNAMIC SEQUENCING DISPLAY PROTOCOLS FOR MEDICAL IMAGING DATA
    33.
    发明申请
    DYNAMIC SEQUENCING DISPLAY PROTOCOLS FOR MEDICAL IMAGING DATA 审中-公开
    用于医学成像数据的动态测序显示协议

    公开(公告)号:US20090276392A1

    公开(公告)日:2009-11-05

    申请号:US12114458

    申请日:2008-05-02

    申请人: John Yan

    发明人: John Yan

    IPC分类号: G06N5/02

    CPC分类号: G06F19/321 G16H40/63

    摘要: Certain embodiments of the present invention provide a method for configuring a medical imaging system, the method comprising: permitting a user to interact with a display protocol, said display protocol further comprising a plurality of rules; allowing said user to select a target rule from said plurality of rules; and facilitating said user to configure a condition for said target rule, wherein said display protocol is capable of a first execution when said condition is satisfied, and wherein the display protocol is capable of a second execution when said condition is not satisfied. In accordance with an embodiment, said condition further comprises at least one of: an entry condition and an exit condition.

    摘要翻译: 本发明的某些实施例提供了一种用于配置医学成像系统的方法,所述方法包括:允许用户与显示协议交互,所述显示协议还包括多个规则; 允许所述用户从所述多个规则中选择目标规则; 并且便于所述用户配置所述目标规则的条件,其中当满足所述条件时,所述显示协议能够进行第一执行,并且其中当所述条件不满足时,所述显示协议能够进行第二执行。 根据一个实施例,所述条件还包括以下中的至少一个:入口条件和退出条件。

    MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE
    34.
    发明申请
    MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE 有权
    MACROCYCLIC LACTONE化合物及其使用方法

    公开(公告)号:US20080138375A1

    公开(公告)日:2008-06-12

    申请号:US11854312

    申请日:2007-09-12

    摘要: The present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of the formula: wherein R1, R2, R3, R5, R6 and R8 are each independently a member selected from the group consisting of H, C1-6 alkyl and OH; R4, R7 and R9 are each independently selected from the group consisting of C1-6 alkoxy and OH; R10 is a member selected from the group consisting of H, —OH, —OP(O)Me2, —O—(CH2)n—OH and —O—(CH2)m—O—(CH2)o— CH3, wherein subscripts n and m are each independently from 2 to 8 and subscript o is from 1 to 6; each of L1 and L4 are independently selected from the group consisting of: each of L2 and L3 are independently selected from the group consisting of: salts, hydrates, isomers, metabolites and prodrugs thereof.

    摘要翻译: 本发明提供一种药物组合物,其包含药学上可接受的赋形剂和下式化合物:其中R 1,R 2,R 3, R 5,R 6和R 8各自独立地是选自H,C 1-6, 烷基和OH; R 4,R 7和R 9各自独立地选自C 1-6 - 烷氧基 和OH; R 10是选自H,-OH,-OP(O)Me 2,-O - (CH 2/2), OH)和-O-(CH 2 CH 2)m -O - (CH 2 CH 2) 其中下标n和m各自独立地为2至8,下标o为1至6; L 1和L 4中的每一个独立地选自:L 2和L 3中的每一个, 独立地选自:其盐,水合物,异构体,代谢物和前药。

    Unpowered, wireless pressure sensor for point-of-care glaucoma diagnosis
    38.
    发明授权
    Unpowered, wireless pressure sensor for point-of-care glaucoma diagnosis 有权
    无动力无线压力传感器,用于治疗青光眼点诊断

    公开(公告)号:US08850895B2

    公开(公告)日:2014-10-07

    申请号:US13330681

    申请日:2011-12-20

    申请人: John Yan

    发明人: John Yan

    IPC分类号: G01L9/00 A61B3/16

    CPC分类号: A61B3/16

    摘要: The disclosed invention describes an unpowered apparatus which can wirelessly sense pressure based on microfluidics for point-of-care glaucoma diagnosis. Moreover, the disclosed invention teaches methods to construct the invention using microfabrication processing. Finally, a detailed and illustrative schematic of the wireless readout system is disclosed.

    摘要翻译: 所公开的发明描述了一种无动力装置,其能够基于用于点护理青光眼诊断的微流体无线地感测压力。 此外,所公开的发明教导了使用微细加工处理来构建本发明的方法。 最后,公开了无线读出系统的详细和说明性示意图。

    Method and apparatus for multi-chip packaging
    39.
    发明授权
    Method and apparatus for multi-chip packaging 有权
    多芯片封装的方法和装置

    公开(公告)号:US08324716B2

    公开(公告)日:2012-12-04

    申请号:US12720547

    申请日:2010-03-09

    申请人: Yong Du John Yan

    发明人: Yong Du John Yan

    IPC分类号: H01L21/00

    摘要: A method and apparatus are provided for multi-chip packaging. A multi-chip package (100) includes a substrate (105) and a plurality of semiconductor dice (110, 120, 130). A first semiconductor die (110) is physically coupled to an upper face of the substrate (105), the first semiconductor die (110) being a smallest one of the plurality of semiconductor dice (110, 120, 130).

    摘要翻译: 提供了用于多芯片封装的方法和装置。 多芯片封装(100)包括基板(105)和多个半导体晶片(110,120,130)。 第一半导体管芯(110)物理耦合到衬底(105)的上表面,第一半导体管芯(110)是多个半导体管芯(110,120,130)中的最小的一个。

    MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE
    40.
    发明申请
    MACROCYCLIC LACTONE COMPOUNDS AND METHODS FOR THEIR USE 审中-公开
    MACROCYCLIC LACTONE化合物及其使用方法

    公开(公告)号:US20110097364A1

    公开(公告)日:2011-04-28

    申请号:US12959153

    申请日:2010-12-02

    摘要: The present invention provides a pharmaceutical composition comprising a pharmaceutically acceptable excipient and a compound of the formula: wherein R1, R2, R3, R5, R6 and R8 are each independently a member selected from the group consisting of H, C1-6 alkyl and OH; R4, R7 and R9 are each independently selected from the group consisting of C1-6 alkoxy and OH; R10 is a member selected from the group consisting of H, —OH, —OP(O)Me2, —O—(CH2)n—OH and —O—(CH2)m—O—(CH2)o—CH3, wherein subscripts n and m are each independently from 2 to 8 and subscript o is from 1 to 6; each of L1 and L4 are independently selected from the group consisting of: each of L2 and L3 are independently selected from the group consisting of: and salts, hydrates, isomers, metabolites and prodrugs thereof.

    摘要翻译: 本发明提供包含药学上可接受的赋形剂和下式化合物的药物组合物:其中R 1,R 2,R 3,R 5,R 6和R 8各自独立地选自H,C 1-6烷基和OH ; R 4,R 7和R 9各自独立地选自C 1-6烷氧基和OH; R 10是选自H,-OH,-OP(O)Me 2,-O-(CH 2)n -OH和-O-(CH 2)m -O-(CH 2)o -CH 3的成员,其中 下标n和m各自独立地为2至8,下标o为1至6; L1和L4中的每一个独立地选自以下各项:L2和L3各自独立地选自:和其盐,水合物,异构体,代谢物和前药。